Systemic lupus erythematosus trials recruiting in District of Columbia

All Systemic lupus erythematosus trials nationally

Cities in District of Columbia

Recruiting trials in District of Columbia

• An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
  NCT05835310 · Phase: Phase 3 · Ages: 5 Years to 17 Years · Sex: All (male and female) · District of Columbia: Washington D.C.
• Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions
  NCT04833465 · Phase: Not specified · Ages: 5 Years to 21 Years · Sex: All (male and female) · District of Columbia: Washington D.C.
• Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
  NCT03816345 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.